The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?

Jean Lanjouw

Working Papers from Yale - Economic Growth Center

Abstract: The decision to require that countries grant product patents for pahrmaceutical innovations as a condition of membership in the World Trade Organization was very contentious. Almost fifty developing countries were not granting patent monopolies for drugs during the period the Uruguay Round of GATT was being debated and these countries fiercely resisted the inclusion of this requirement, claiming that vastly higher drug prices would be associated with such patents.

Keywords: PHARMACEUTICAL INDUSTRY; PATENTS; INNOVATIONS (search for similar items in EconPapers)
JEL-codes: L65 O31 O32 (search for similar items in EconPapers)
Pages: 53 pages
Date: 1997
References: Add references at CitEc
Citations: View citations in EconPapers (14)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Working Paper: The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering? (2003)
Working Paper: The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"? (1998)
Working Paper: The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"? (1997)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fth:yalegr:775

Access Statistics for this paper

More papers in Working Papers from Yale - Economic Growth Center U.S.A.; YALE UNIVERSITY, ECONOMIC GROWTH CENTER, YALE STATION NEW-HAVEN CONNECTICUT 06520 U.S.A. Contact information at EDIRC.
Bibliographic data for series maintained by Thomas Krichel ().